Purdue Ventures, which manages three funds to support Purdue University-connected startups, has invested $250,000 in Trio Pharmaceuticals Inc., a cancer immunotherapeutics startup founded by a Purdue University biophysics and structural biology alumnus. The company’s antibody-based therapeutics aim to strengthen the immune system to eradicate cancer. Purdue Ventures’ investment is part of a larger $2.2 million series seed-funding round that includes investments from investor groups in the U.S...